Yuandong Biotech announced that Chengdu Shuode Pharmaceutical Co., Ltd., a wholly-owned subsidiary, recently received the “Drug Registration Certificate” approved and issued by the State Drug Administration. The name of the drug is a hydrated chloraldehyde enema, the dosage form is an enema, the specification is 1.34g: 0.5g, and the registered classification is a chemical category 3. The main component of the hydrated chloraldehyde enema is hydrated chloraldehyde. The indications are anticonvulsants under sedation, hypnosis and supervision conditions before examination and operation in children. This drug is the second domestic company approved for marketing and is considered to have passed the consistency evaluation. According to data from public hospitals in key provinces and cities within the United States, sales of hydrated chloraldehyde were about 14.81 million yuan in Q1-Q3 in 2024, an increase of 57.04% over the previous year, of which sales of hydrated chloraldehyde enema were 3.29 million yuan.

Yuandong Biotech announced that Chengdu Shuode Pharmaceutical Co., Ltd., a wholly-owned subsidiary, recently received the “Drug Registration Certificate” approved and issued by the State Drug Administration. The name of the drug is a hydrated chloraldehyde enema, the dosage form is an enema, the specification is 1.34g: 0.5g, and the registered classification is a chemical category 3. The main component of the hydrated chloraldehyde enema is hydrated chloraldehyde. The indications are anticonvulsants under sedation, hypnosis and monitoring conditions before examination and operation in children. This drug is the second domestic company approved for marketing and is considered to have passed the consistency evaluation. According to data from public hospitals in key provinces and cities within the United States, sales of hydrated chloraldehyde were about 14.81 million yuan in Q1-Q3 in 2024, an increase of 57.04% over the previous year, of which sales of hydrated chloraldehyde enema were 3.29 million yuan.